Over the last 7 days, the Australian market has risen 1.7%, driven by gains of 12% in the Materials sector, although the Financials sector is down 3.2%. Over the past 12 months, the market is up 17%, with earnings forecast to grow by 12% annually. In this context, identifying undervalued small-cap stocks with insider buying can be a strategic move for investors looking to capitalize on potential growth opportunities within a robust market environment. Top 10 Undervalued Small Caps With Insider Buying In Australia Name PE PS Discount to Fair Value Value Rating GWA Group 16.3x 1.5x 41.91% ★★★★★★ Magellan Financial Group 7.5x 4.8x 37.48% ★★★★★☆ Bigtincan Holdings NA 1.1x 48.65% ★★★★★☆ Tabcorp Holdings NA 0.5x 20.01% ★★★★★☆ Mader Group 21.0x 1.4x 49.66% ★★★★☆☆ Centuria Capital Group 23.2x 5.2x 41.48% ★★★★☆☆ Eagers Automotive 11.0x 0.3x 36.82% ★★★★☆☆ Dicker Data 21.1x 0.8x -73.23% ★★★☆☆☆ Coventry Group 221.9x 0.4x -11.64% ★★★☆☆☆ Corporate Travel Management 21.9x 2.6x -2.46% ★★★☆☆☆ Click here to see the full list of 24 stocks from our Undervalued ASX Small Caps With Insider Buying screener. Let's review some notable picks from our screened stocks. Eagers Automotive Simply Wall St Value Rating: ★★★★☆☆ Overview: Eagers Automotive is a major car retailing company with operations primarily focused on the automotive sector and a market cap of approximately A$3.81 billion. Operations: The company generates revenue primarily from car retailing, with a gross profit margin of 18.37% as of the latest period. Operating expenses and non-operating expenses are significant cost components, impacting net income margins which stood at 2.47%. PE: 11.0x Eagers Automotive, a small Australian company, recently reported A$5.46 billion in sales for the first half of 2024, up from A$4.82 billion the previous year. Despite this growth, net income dipped to A$116 million from A$137.76 million. Insider confidence is evident with Nicholas Politis purchasing 200,000 shares worth approximately A$2.09 million between July and August 2024. The company's reliance on external borrowing highlights its higher risk profile but also underscores potential undervaluation opportunities for investors seeking growth in smaller companies. Navigate through the intricacies of Eagers Automotive with our comprehensive valuation report here. Explore historical data to track Eagers Automotive's performance over time in our Past section. ASX:APE Share price vs Value as at Oct 2024 Neuren Pharmaceuticals Simply Wall St Value Rating: ★★★★★☆ Overview: Neuren Pharmaceuticals develops therapies for neurodevelopmental disorders and has a market cap of A$1.20 billion. Operations: Neuren Pharmaceuticals generates revenue primarily from product sales, with recent figures showing a significant increase to A$193.34 million as of June 30, 2024. The company's cost of goods sold (COGS) for the same period was A$32.90 million, resulting in a gross profit margin of 82.98%. Operating expenses are relatively low compared to revenue, at A$5.28 million for the quarter ending June 30, 2024. Net income reached A$117.29 million with a net income margin of 60.67% during this period. PE: 16.5x Neuren Pharmaceuticals has caught attention with its insider confidence, as insiders have been buying shares consistently over the past six months. Despite a dip in earnings for the half year ending June 30, 2024—sales dropped to A$24.33 million from A$62.93 million—the company remains optimistic about future growth, forecasting net sales of A$340-370 million for 2024. Recent Phase 2 trials also showed promising results for Angelman syndrome treatment, potentially boosting long-term prospects. Delve into the full analysis valuation report here for a deeper understanding of Neuren Pharmaceuticals. Understand Neuren Pharmaceuticals' track record by examining our Past report. ASX:NEU Share price vs Value as at Oct 2024 Sims Simply Wall St Value Rating: ★★★★☆☆ Overview: Sims operates in the recycling industry, focusing on metal and electronics recycling through segments like Global Trading, North America Metals, Sims Lifecycle Services, and Australia/New Zealand Metals, with a market cap of A$3.50 billion. Operations: The company generates revenue primarily from its North America Metals (A$4.49 billion) and Australia/New Zealand Metals (A$1.60 billion) segments, with additional contributions from Global Trading and Sims Lifecycle Services. Over the observed periods, gross profit margins have fluctuated between 8.37% and 14.38%, reflecting variations in cost of goods sold relative to revenue. Operating expenses include significant allocations for depreciation and amortization, which impact net income margins ranging from -5.39% to 6.46%. PE: 1365.7x Sims, a small Australian company, recently reported A$7.22 billion in sales for the year ending June 30, 2024, up from A$6.66 billion last year. Despite this increase, they posted a net loss of A$57.8 million compared to a net income of A$181.1 million previously. Insider confidence is evident with notable share purchases over the past six months. The company's earnings are forecasted to grow by 41% annually despite lower profit margins and reliance on external borrowing for funding. Click here and access our complete valuation analysis report to understand the dynamics of Sims. Examine Sims' past performance report to understand how it has performed in the past. ASX:SGM Share price vs Value as at Oct 2024 Seize The Opportunity Navigate through the entire inventory of 24 Undervalued ASX Small Caps With Insider Buying here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Looking For Alternative Opportunities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:APE ASX:NEU and ASX:SGM. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
3 Undervalued Small Caps In Australia With Insider Buying
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...